• Home

  • Documents

  • Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related...
76

Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders

Embed Size (px)

Citation preview

Page 1: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 2: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 3: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 4: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 5: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 6: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 7: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 8: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 9: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 10: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 11: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 12: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 13: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 14: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 15: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 16: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 17: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 18: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 19: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 20: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 21: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 22: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 23: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 24: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 25: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 26: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 27: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 28: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 29: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 30: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 31: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 32: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 33: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 34: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 35: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 36: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 37: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 38: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 39: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 40: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 41: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 42: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 43: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 44: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 45: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 46: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 47: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 48: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 49: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 50: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 51: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 52: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 53: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 54: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 55: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 56: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 57: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 58: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 59: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 60: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 61: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 62: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 63: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 64: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 65: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 66: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 67: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 68: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 69: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 70: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 71: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 72: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 73: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 74: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 75: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders
Page 76: Transgenic animal in vivo screening models for treatment of glutaminyl cyclase isoenzyme- related disorders

Inhibition of glutaminyl cyclase prevents pGlu-A formation after intracorticalhippocampal microinjection in vivo in situ

Inhibition of glutaminyl cyclase prevents pGlu-A formation after intracorticalhippocampal microinjection in vivo in situ

Documents
Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase

Molecular Characterization of a Novel Intracellular ADP-Ribosyl Cyclase

Documents
Comparative analysis of diguanylate cyclase and phosphodiesterase genes in Klebsiella pneumoniae

Comparative analysis of diguanylate cyclase and phosphodiesterase genes in Klebsiella pneumoniae

Documents
Transgenic animals overexpressing glutaminyl peptide cyclotransferase genes for in vivo screening of effectors

Transgenic animals overexpressing glutaminyl peptide cyclotransferase genes for in vivo screening of effectors

Documents
Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC

Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC

Documents
Cell fractionation, detergent sensitivity and solubilization of Dictyostelium adenylate cyclase and guanylate cyclase

Cell fractionation, detergent sensitivity and solubilization of Dictyostelium adenylate cyclase and guanylate cyclase

Documents
Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes

Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes

Documents
Tissue differential expression of lycopene β-cyclase gene in papaya

Tissue differential expression of lycopene β-cyclase gene in papaya

Documents
NOVEL GENES RELATED TO GLUTAMINYL CYCLASE

NOVEL GENES RELATED TO GLUTAMINYL CYCLASE

Documents
Preparation of imidazolyl thiourea derivs. as glutaminyl cyclase inhibitors for treating cancer, nervous system disorders, and other diseases

Preparation of imidazolyl thiourea derivs. as glutaminyl cyclase inhibitors for treating cancer, nervous system disorders, and other diseases

Documents
Effects of cadmium on renal cortical adenylate cyclase

Effects of cadmium on renal cortical adenylate cyclase

Documents
Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β †

Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β †

Documents
Continuous assays of glutaminyl cyclase: from development to application

Continuous assays of glutaminyl cyclase: from development to application

Documents
Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy

Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy

Documents
Glutaminyl Cyclases as Novel Targets for the Treatment of Septic Arthritis

Glutaminyl Cyclases as Novel Targets for the Treatment of Septic Arthritis

Documents
Glycogen Phosphorylase Isoenzyme BB Plasma Concentration Is Elevated in Pregnancy and Preterm Preeclampsia

Glycogen Phosphorylase Isoenzyme BB Plasma Concentration Is Elevated in Pregnancy and Preterm Preeclampsia

Documents
Regulation of vascular guanylyl cyclase by endothelial nitric oxide-dependent posttranslational modification

Regulation of vascular guanylyl cyclase by endothelial nitric oxide-dependent posttranslational modification

Documents
Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease

Transgenic mice expressing Aβ peptide and glutaminyl cyclase and their uses in screening drugs for treating Alzheimer's disease

Documents
Diferentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation

Diferentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation

Documents
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease

Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease

Documents
Isoenzyme electrophoretic patterns in discus fish

Isoenzyme electrophoretic patterns in discus fish

Documents
Heterologous Expression and Characterization of Human Glutaminyl Cyclase:  Evidence for a Disulfide Bond with Importance for Catalytic Activity

Heterologous Expression and Characterization of Human Glutaminyl Cyclase:  Evidence for a Disulfide Bond with Importance for Catalytic Activity

Documents
Use of effectors of glutaminyl and glutamate cyclases for therapy

Use of effectors of glutaminyl and glutamate cyclases for therapy

Documents
Preparation of glutaminyl cyclase inhibitors for use in treating neurological diseases

Preparation of glutaminyl cyclase inhibitors for use in treating neurological diseases

Documents
Inhibitory role of monovalent ions on rat brain cortex adenylyl cyclase activity

Inhibitory role of monovalent ions on rat brain cortex adenylyl cyclase activity

Documents
Methods of diagnosing inflammatory diseases by determining pyroglutamate- modified MCP- 1 and screening methods for inhibitors of glutaminyl cyclase

Methods of diagnosing inflammatory diseases by determining pyroglutamate- modified MCP- 1 and screening methods for inhibitors of glutaminyl cyclase

Documents
Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo

Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo

Documents
Guanylate-cyclase-inhibitory protein is a frog retinal Ca2+-binding protein related to mammalian guanylate-cyclase-activating proteins

Guanylate-cyclase-inhibitory protein is a frog retinal Ca2+-binding protein related to mammalian guanylate-cyclase-activating proteins

Documents
Inhibition of adenylyl cyclase isoforms V and VI by various Gbg subunits

Inhibition of adenylyl cyclase isoforms V and VI by various Gbg subunits

Documents
CARACTERIZACIÓN ISOENZIMÁTICA DE CULTIVARES DE NOPAL (Opuntia spp.) Isoenzyme characterization of nopal cultivars (Opuntia spp

CARACTERIZACIÓN ISOENZIMÁTICA DE CULTIVARES DE NOPAL (Opuntia spp.) Isoenzyme characterization of nopal cultivars (Opuntia spp

Documents